Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies

Volkow, N.D., Fowler, J.S., Wang, G.-J. · 2002 · Behavioural Pharmacology

Abstract

The involvement of dopamine (DA) in drug reinforcement is well established, but much less in known about its contribution to addiction. We have used positron emission tomography to investigate in humans the role of DA in drug reinforcement, addiction and drug vulnerability. We have shown that during drug intoxication increases in striatal DA are associated with the drug's reinforcing effects only if the DA changes occur rapidly. These results corroborate the relevance of drug-induced DA increases and of pharmacokinetics in the rewarding effects of drugs in humans. During withdrawal, we have shown significant reductions in DA D(2) receptors and in DA release in drug abusers, which is likely to result in decreased sensitivity to non-drug-related reinforcing stimuli. The DA D(2) reductions were associated with decreased activity in the orbitofrontal cortex, which we postulate is one of the mechanisms underlying compulsive drug administration in the addict. In fact, during craving the orbitofrontal cortex becomes hyperactive in proportion to the desire for the drug. In non-drug-abusing subjects striatal DA D(2) receptors levels predicted the reinforcing responses to stimulant drugs, providing evidence that striatal DA D(2) receptors modulate reinforcing responses to stimulants in humans and may contribute to the predisposition for drug self-administration.

Overview

Integrity signals

Registry

Crossref · 10.1097/00008877-200209000-00008

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 61 references

Research works printed but not linked: 1

  1. Volkow, 1999e, Am J Psychiatry, 156, 1440, 10.1176/ajp.156.1.19 · DOI · Paper page

Cited by

See all 452

Metadata

Authors
Volkow, N. D., Fowler, J. S., & Wang, G.-J.
Affiliations
Brookhaven National Laboratory (US)
Corresponding author
Volkow, N.D.
Venue
Behavioural Pharmacology
Published
2002-09
Volume
13
Issue
5
Pages
355-366
ISSN
0955-8810 (ISSN-L)
OpenAlex
W2038246573
Cited by
398
References
61
Citations by year
2026: 5 · 2025: 7 · 2024: 9 · 2023: 10 · 2022: 33 · 2021: 8 · 2020: 31 · 2019: 8 · 2018: 4 · 2017: 12 · 2016: 15 · 2015: 11 · 2014: 26 · 2013: 14 · 2012: 22
FWCI
1.44
Type
journal article
Language
en
Open access
closed
Locations
  • Behavioural Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Office of National Drug Control Policy
  • National Institutes of Health (5r01da009490-08)
  • National Institute on Alcohol Abuse and Alcoholism (AA-09481, R01AA009481)
  • National Institute on Drug Abuse (DA-06891, DA-09490, DA-06278, R01DA006278, R01DA006891)
  • Biological and Environmental Research
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
dopamine, drug reinforcement, addiction, drug vulnerability, striatal dopamine D2 receptors, dopamine release, withdrawal, orbitofrontal cortex, craving, stimulants, self-administration, pharmacokinetics
MeSH terms
Dopamine, Humans, Membrane Glycoproteins, Nerve Tissue Proteins, Neurons, Reinforcement, Psychology, Tomography, Emission-Computed, Receptors, Dopamine D2, Substance-Related Disorders, Membrane Transport Proteins, Dopamine Plasma Membrane Transport Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. https://app.cochat.ai/papers/10.1097/00008877-200209000-00008
The paper
Volkow, N. D., Fowler, J. S., & Wang, G.-J. (2002). Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. Behavioural Pharmacology. https://doi.org/10.1097/00008877-200209000-00008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.